Human interleukin-2 Completed Phase 3 Trials for Cytokine Release Syndrome / Pulmonary Fibrosis / Coronavirus Disease 2019 (COVID‑19) / Acute Respiratory Distress Syndrome Caused by COVID-19 Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT04979884Safety and Effectiveness of Cyclosporin in the Management of COVID19 ARDS Patients in Alexandria University Hospital